Cart
sales@molnova.com
Rabeximod
CAS No. 872178-65-9
Rabeximod( —— )
Catalog No. M34686 CAS No. 872178-65-9
Rabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 392 | Get Quote |
|
| 5MG | 610 | Get Quote |
|
| 10MG | 867 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRabeximod
-
NoteResearch use only, not for human use.
-
Brief DescriptionRabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models.
-
DescriptionRabeximod is a potent immunomodulator that reduces the severity of autoimmune diseases in rat models. Rabeximod inhibits arthritis in a time-dependent manner by stimulating TLR2 and TLR4 downstream to block the activation of inflammatory cells, most likely macrophages. Rabeximod effectively reduces brain antigen presentation in mice during anti-inflammatory therapy for traumatic brain injury.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorTLR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number872178-65-9
-
Formula Weight409.91
-
Molecular FormulaC22H24ClN5O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(NCCN(C)C)=O)N1C=2C(C=3C1=CC=C(Cl)C3)=NC=4C(N2)=CC(C)=C(C)C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Semapimod
Semapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production, inhibits TLR4 signaling (IC50=0.3 uM) .
-
ANA975
ANA975 is an oral prodrug of the TLR-7 agonist Isatoribine (ANA245;7-Thia-8-oxoguanosine) against hepatitis C virus (HCV) infection.
-
CPG-52364
CPG-52364 (CPG52364) is an orally available, small molecule TLR7/8/9 antagonist for the treatment of systemic lupus erythematosus and other autoimmune disorders.
